Pediatric allergic rhinitis: Treatment

Immunology and Allergy Clinics of North America

Volumn 25, Issue 2, 2005, Pages 283-299

  Lai, Lien ^a   Casale, Thomas B ^a   Stokes, Jeffrey ^a  

^a CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; AZELASTINE; BECLOMETASONE DIPROPIONATE; BROMPHENIRAMINE; BUDESONIDE; CETIRIZINE; CHLORPHENIRAMINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DECONGESTIVE AGENT; DESLORATADINE; DIPHENHYDRAMINE; EPHEDRINE; FEXOFENADINE; FLUNISOLIDE; FLUTICASONE PROPIONATE; HISTAMINE RELEASE INHIBITOR; HYDROXYZINE; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LORATADINE; MAST CELL STABILIZER; MOMETASONE FUROATE; MONTELUKAST; OMALIZUMAB; OXYMETAZOLINE; PHENYLEPHRINE; PSEUDOEPHEDRINE; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG;

ALLERGIC RHINITIS; ALLERGY TEST; ANAPHYLAXIS; BITTER TASTE; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; COGNITIVE DEFECT; COMORBIDITY; DROWSINESS; DRY NOSE; EPISTAXIS; EXCITABILITY; GROWTH INHIBITION; GROWTH RETARDATION; HEART PALPITATION; HUMAN; IMMUNOTHERAPY; INSOMNIA; IRRITABILITY; LEARNING DISORDER; NERVOUSNESS; NOSE SEPTUM PERFORATION; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; QUALITY OF LIFE; REBOUND; RESTLESSNESS; REVIEW; RHINORRHEA; SEDATION; SEIZURE; SOMNOLENCE; SYMPTOMATOLOGY; TACHYCARDIA; TACHYPHYLAXIS; TREATMENT OUTCOME;

ALLERGENS; ANTIBODIES, MONOCLONAL; CHILD; CHOLINERGIC ANTAGONISTS; HISTAMINE H1 ANTAGONISTS; HUMANS; LEUKOTRIENE ANTAGONISTS; NASAL DECONGESTANTS; RHINITIS;

EID: 18844365173     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2005.02.003     Document Type: Review

References (67)

1. J.G. Collins Prevalence of selected chronic conditions: United States, 1990-1992 US Department of Health and Human Services Publication #97-1522 1997 National Center for Health Statistics Hyattsville (MD) 1 89
2. S.G. Johansson, T. Bieber, and R. Dahl Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003 J Allergy Clin Immunol 113 5 2004 832 836
3. N.P. Barney, and F.M. Graziano Allergic and immunologic diseases of the eye N.F. Adkinson Jr J.W. Yunginger W.W. Busse Middleton's allergy: principles and practice 6th edition 2003 Mosby Philadelphia 1599 1618
4. American Academy of Allergy Asthma and Immunology The allergy report. Allergic disorders: promoting best practices 2001 Available at: www.theallergyreport.org Accessed November 12, 2004
5. J. Bousquet, P. Van Cauwenberge, N. Khaltaev for the ARIA Workshop Group World Health Organization Allergic rhinitis and its impact on asthma: ARIA guidelines J Allergy Clin Immunol 108 5 2001 S147 S332
6. D. Strachan, B. Sibbald, and S. Weiland Worldwide variations in prevalence of symptoms of allergic rhino-conjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC) Pediatr Allergy Immunol 8 4 1997 161 176
7. M.S. Dykewicz, S. Fineman, and D.P. Skoner Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology Ann Allergy Asthma Immunol 81 5 Pt 2 1998 478 518
8. B.G. Bender, and T.J. Fischer Differential impacts of allergic rhinitis and allergy medications on childhood learning Pediatr Asthma Allergy Immunol 12 1998 1 13
9. P. Fireman Therapeutic approaches to allergic rhinitis: treating the child J Allergy Clin Immunol 105 6 Pt 2 2000 S616 S621
10. G. Lack Pediatric allergic rhinitis and comorbid disorders J Allergy Clin Immunol 108 1 Suppl 2001 S9 S15
11. G.S. Rachelefsky National guidelines needed to manage rhinitis and prevent complications Ann Allergy Asthma Immunol 82 1999 296 305
12. L.A. Tanner, M. Reilly, and E.O. Meltzer Effect of fexofenadine HCl on quality of life and work, classroom, and daily activity impairment in patients with seasonal allergic rhinitis Am J Manag Care Suppl 2 1999 S235 S247
13. E.F. Juniper, G.H. Guyatt, and J. Dolovich Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials J Allergy Clin Immunol 93 1994 413 423
14. E.O. Meltzer Quality of life in adults and children with allergic rhinitis J Allergy Clin Immunol 108 1 Suppl 2001 S45 S53
15. D.G. Peroni, G.L. Piacentini, and L. Alfonsi Rhinitis in pre-school children: prevalence, association with allergic diseases and risk factors Clin Exp Allergy 33 2003 1349 1354
16. D.P. Skoner Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis J Allergy Clin Immunol 108 1 Suppl 2001 S2 S8
17. D.S. Pearlman Pathophysiology of the inflammatory response J Allergy Clin Immunol 104 1999 S132 S137
18. S.P. Galant, and R. Wilkinson Clinical prescribing of allergic rhinitis medication in the preschool and young school-age child: what are the options? BioDrugs 15 7 2001 453 463
19. L. Smith Special considerations for the child with airway disease J Allergy Clin Immunol 101 2 Pt 2 1998 S370 S372
20. I. Terreehorst, E. Hak, and A.J. Oosting Evaluation of impermeable covers for bedding in patients with allergic rhinitis N Engl J Med 349 2003 237 246
21. W.J. Morgan, E.F. Crain, and R.S. Gruchalla Results of a home-based environmental intervention among urban children with asthma N Engl J Med 351 11 2004 1068 1080
22. J. Bousquet, P. van Cauwenberge, and N. Khaltaev Workshop Expert Panel. Allergic Rhinitis and its Impact on Asthma (ARIA): executive summary of the workshop report Allergy 57 2002 841 855
23. P. Van Cauwenberge, C. Bachert, and G. Passalacqua Consensus statement on the treatment of allergic rhinitis Allergy 55 2 2000 116 134
24. E.O. Meltzer Treatment options for the child with allergic rhinitis Clin Pediatr (Phila) 37 1 1998 1 10
25. E.F. Vuurman, M.M. Uiterwijk, and L.M. van Veggel Seasonal allergic rhinitis and antihistamine effects on children's learning Ann Allergy 71 1993 121 126
26. H. Milgrom, and B. Bender Adverse effects of medications for rhinitis Ann Allergy Asthma Immunol 78 1997 439 446
27. U. Wahn, E.O. Meltzer, and A.F. Finn Jr Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis J Allergy Clin Immunol 111 4 2003 763 769
28. F.E. Simons, B.M. Prenner, A. Finn Jr for the Desloratadine Study Group Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis J Allergy Clin Immunol 111 3 2003 617 622
29. S.A. Gillman, M. Blatter, and J.J. Condemi The health-related quality of life effects of once-daily cetirizine HCl syrup in children with seasonal allergic rhinitis Clin Pediatr (Phila) 41 9 2002 687 696
30. G. Bruttmann, D. Charpin, and J. Germouty Evaluation of the efficacy and safety of loratadine in perennial allergic rhinitis J Allergy Clin Immunol 83 2 Pt 1 1989 411 416
31. D.F. Graft, D.I. Bernstein, and A. Goldsobel Safety of fexofenadine in children treated for seasonal allergic rhinitis Ann Allergy Asthma Immunol 87 1 2001 22 26
32. E.O. Meltzer, P. Scheinmann, and J.E. Rosado Pinto Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis-a pooled analysis of three studies Pediatr Allergy Immunol 15 3 2004 253 260
33. P. Van Cauwenberge, and E.F. Juniper Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis Clin Exp Allergy 30 6 2000 891 899
34. D.J. Tinkel, J. Kemp, and D.Q. Mitchell Treatment of seasonal allergic rhinitis in children with cetirizine and chlorpheniramine. A multi-center study Pediatr Asthma Allergy Immunol 10 1996 9 17
35. Y. Baelde, and P. Dupont Cetirizine in children with chronic allergic rhinitis Drug Invest 4 1992 466 472
36. K.H. Ng, D. Chong, and C.K. Wong Central nervous system side effects of first- and second-generation antihistamines in school children with perennial allergic rhinitis: a randomized, double-blind, placebo-controlled comparative study Pediatrics 113 2 2004 e116 e121
37. F. Hampel, P. Ratner, and L. Mansfield Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis Ann Allergy Asthma Immunol 91 4 2003 354 361
38. D. Herman, R. Garay, and M. Le Gal A randomized double-blind placebo controlled study of azelastine nasal spray in children with perennial rhinitis Int J Pediatr Otorhinolaryngol 39 1 1997 1 8
39. C.F. LaForce, J. Corren, W.J. Wheeler for the Rhinitis Study Group Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine Ann Allergy Asthma Immunol 93 2 2004 154 159
40. G.G. Kay The effects of antihistamines on cognition and performance J Allergy Clin Immunol 105 2000 S622 S627
41. A. Yáñez, and G.J. Rodrigo Intranasal corticosteroids versus topical H receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis Ann Allergy Asthma Immunol 89 2002 479 484
42. D.B. Allen Systemic effects of intranasal steroids: an endocrinologist's perspective J Allergy Clin Immunol 106 2000 S179 S190
43. S.P. Galant, I.R. Melamed, and A.S. Nayak Lack of effect of fluticasone propionate aqueous nasal spray on the hypothalamic-pituitary-adrenal axis in 2- and 3-year-old patients Pediatrics 112 1 Pt 1 2003 96 100
44. G.K. Scadding Corticosteroids in the treatment of pediatric allergic rhinitis J Allergy Clin Immunol 108 2001 S59 S64
45. Skoner D.P., Rachelefsky G.S., Meltzer E.O., et al. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. Pediatrics 2000;105(2):E23, 1-7
46. Schenkel E.J., Skoner D.P., Bronsky E.A., et al. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics 2000;105(2):E22, 1-7
47. D.B. Allen, E.O. Meltzer, and R.F. Lemanske Jr No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year Allergy Asthma Proc 23 2002 407 413
48. D.P. Skoner, D. Gentile, and B. Angelini The effects of intranasal triamcinolone acetonide and intranasal fluticasone propionate on short-term bone growth and HPA axis in children with allergic rhinitis Ann Allergy Asthma Immunol 90 2003 56 62
49. C. Moller, H. Ahlstrom, and K.A. Henricson Safety of nasal budesonide in the long-term treatment of children with perennial rhinitis Clin Exp Allergy 33 2003 816 822
50. Skoner D.P., Gentile D.A., Doyle W.J., et al. Effect of 1-year treatment with triamcinolone acetonide aqueous (TAA) nasal spray on growth velocity and HPA function in children with allergic rhinitis [abstract 39]. In: Programs and abstracts of the annual meeting of the American College of Allergy Asthma and Immunology. Boston, November 12-17, 2004. p.12
51. C. Moller, H. Ahlstrom, and K.A. Henricson Safety of nasal budesonide in the long-term treatment of children with perennial rhinitis Clin Exp Allergy 33 6 2003 816 822
52. P.H. Ratner, P.M. Ehrlich, and S.M. Fineman Use of intranasal cromolyn sodium for allergic rhinitis Mayo Clin Proc 77 4 2002 350 354
53. E.O. Meltzer Clinical evidence for antileukotriene therapy in the management of allergic rhinitis Ann Allergy Asthma Immunol 88 Suppl 2002 23 29
54. J. Van Adelsberg, G. Philip, C.F. LaForce Montelukast Spring Rhinitis Investigator Group Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis Ann Allergy Asthma Immunol 90 2 2003 214 222
55. G. Philip, K. Malmstrom, F.C. Hampel Montelukast Spring Rhinitis Study Group Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring Clin Exp Allergy 32 7 2002 1020 1028
56. J. Van Adelsberg, G. Philip, and A.J. Pedinoff Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period Allergy 58 2003 1268 1276
57. P. Chervinsky, G. Philip, and M.P. Malice Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies Ann Allergy Asthma Immunol 92 3 2004 367 373
58. A. Nayak A review of montelukast in the treatment of asthma and allergic rhinitis Expert Opin Pharmacother 5 3 2004 679 686
59. A.S. Nayak, G. Philip, S. Lu Montelukast Fall Rhinitis Investigator Group Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall Ann Allergy Asthma Immunol 88 6 2002 592 600
60. R.A. Nathan Pharmacotherapy for allergic rhinitis: a critical review of leukotriene receptor antagonists compared with other treatments Ann Allergy Asthma Immunol 90 2003 182 191
61. E.O. Meltzer, H.A. Orgel, and R. Biondi Ipratropium nasal spray in children with perennial rhinitis Ann Allergy Asthma Immunol 78 5 1997 485 491
62. J. Bousquet, and R.F. Lockey Allergen immunotherapy: therapeutic vaccines for allergic disease: WHO position paper Allergy 53 1998 1 42
63. R.N. Ross, H.S. Nelson, and I. Fingold Effectiveness of specific immunotherapy in the treatment of allergic rhinitis: an analysis of randomized, prospective, single- or double-blind, placebo-controlled studies Clin Ther 22 2000 342 350
64. E.C. TePas, and D.T. Umetsu Immunotherapy of asthma and allergic diseases Curr Opin Pediatr 12 2000 574 578
65. C. Moller, S. Dreborg, and H.A. Ferdousi Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study) J Allergy Clin Immunol 109 2 2002 251 256
66. X. Yang Does allergen immunotherapy alter the natural course of allergic disorders? Drugs 61 3 2001 365 374
67. P. Chervinsky, T. Casale, and R. Townley Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis Ann Allergy Asthma Immunol 91 2003 160 167